Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

High mitochondrial accumulation of new gadolinium(III) agents within tumour cells.

Morrison DE, Aitken JB, de Jonge MD, Ioppolo JA, Harris HH, Rendina LM.

Chem Commun (Camb). 2014 Mar 4;50(18):2252-4. doi: 10.1039/c3cc46903d. Epub 2013 Dec 19.

PMID:
24352097
2.

Synthesis and biological evaluation of a class of mitochondrially-targeted gadolinium(III) agents.

Morrison DE, Aitken JB, de Jonge MD, Issa F, Harris HH, Rendina LM.

Chemistry. 2014 Dec 8;20(50):16602-12. doi: 10.1002/chem.201404107. Epub 2014 Oct 16.

PMID:
25323923
3.

Organometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death.

Nazarov AA, Gardini D, Baquié M, Juillerat-Jeanneret L, Serkova TP, Shevtsova EP, Scopelliti R, Dyson PJ.

Dalton Trans. 2013 Feb 21;42(7):2347-50. doi: 10.1039/c2dt31936e. Epub 2012 Dec 5.

PMID:
23223548
4.

Water-soluble Co(III) complexes of substituted phenanthrolines with cell selective anticancer activity.

Jagadeesan S, Balasubramanian V, Baumann P, Neuburger M, Häussinger D, Palivan CG.

Inorg Chem. 2013 Nov 4;52(21):12535-44. doi: 10.1021/ic4016228. Epub 2013 Oct 15.

PMID:
24127683
5.

Cytotoxic activity of Gd(III)- and Dy(III)-complexes.

Kostova I, Kiefer W, Momekov G.

Arch Pharm (Weinheim). 2007 Dec;340(12):642-9.

PMID:
17994606
6.

Development of a Gd(III)-based receptor-induced magnetization enhancement (RIME) contrast agent for β-glucuronidase activity profiling.

Chen SH, Kuo YT, Singh G, Cheng TL, Su YZ, Wang TP, Chiu YY, Lai JJ, Chang CC, Jaw TS, Tzou SC, Liu GC, Wang YM.

Inorg Chem. 2012 Nov 19;51(22):12426-35. doi: 10.1021/ic301827p. Epub 2012 Nov 1.

PMID:
23116118
7.

Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.

Hickey JL, Ruhayel RA, Barnard PJ, Baker MV, Berners-Price SJ, Filipovska A.

J Am Chem Soc. 2008 Sep 24;130(38):12570-1. doi: 10.1021/ja804027j. Epub 2008 Aug 26.

PMID:
18729360
8.

Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.

Song XD, Kong X, He SF, Chen JX, Sun J, Chen BB, Zhao JW, Mao ZW.

Eur J Med Chem. 2017 Sep 29;138:246-254. doi: 10.1016/j.ejmech.2017.06.038. Epub 2017 Jun 23.

PMID:
28668477
9.

New titanocene derivatives with high antiproliferative activity against breast cancer cells.

Saturnino C, Sirignano E, Botta A, Sinicropi MS, Caruso A, Pisano A, Lappano R, Maggiolini M, Longo P.

Bioorg Med Chem Lett. 2014 Jan 1;24(1):136-40. doi: 10.1016/j.bmcl.2013.11.058. Epub 2013 Dec 3.

PMID:
24332626
10.

Cancer cell cytotoxicity of cyclometalated compounds obtained with osmium(II) complexes.

Boff B, Gaiddon C, Pfeffer M.

Inorg Chem. 2013 Mar 4;52(5):2705-15. doi: 10.1021/ic302779q. Epub 2013 Feb 21.

PMID:
23427955
11.

Antiproliferative effects of metal complexes of new isatin hydrazones against HCT116, MCF7 and HELA tumour cell lines.

Kandile NG, Mohamed MI, Ismaeel HM.

J Enzyme Inhib Med Chem. 2012 Jun;27(3):330-8. doi: 10.3109/14756366.2011.588950. Epub 2011 Jun 24.

PMID:
21699460
12.

Structures and anti-cancer properties of two binuclear copper complexes.

Qin XY, Yang LC, Le FL, Yu QQ, Sun DD, Liu YN, Liu J.

Dalton Trans. 2013 Oct 1;42(41):14681-4. doi: 10.1039/c3dt51548f.

PMID:
24026617
13.

Apoptosis and anti-tumour activities of manganese(III)-salen and -salphen complexes.

Ansari KI, Kasiri S, Grant JD, Mandal SS.

Dalton Trans. 2009 Oct 28;(40):8525-31. doi: 10.1039/b905276c. Epub 2009 Aug 20.

PMID:
19809727
14.

Membrane localized iridium(III) complex induces endoplasmic reticulum stress and mitochondria-mediated apoptosis in human cancer cells.

Cao R, Jia J, Ma X, Zhou M, Fei H.

J Med Chem. 2013 May 9;56(9):3636-44. doi: 10.1021/jm4001665. Epub 2013 Apr 25.

PMID:
23594206
15.

Selenium-containing naphthalimides as anticancer agents: design, synthesis and bioactivity.

Zhao L, Li J, Li Y, Liu J, Wirth T, Li Z.

Bioorg Med Chem. 2012 Apr 15;20(8):2558-63. doi: 10.1016/j.bmc.2012.02.049. Epub 2012 Mar 1.

PMID:
22436386
16.

Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.

Ramakrishnan S, Shakthipriya D, Suresh E, Periasamy VS, Akbarsha MA, Palaniandavar M.

Inorg Chem. 2011 Jul 18;50(14):6458-71. doi: 10.1021/ic1024185. Epub 2011 Jun 14.

PMID:
21671566
17.

Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines.

Zanella A, Gandin V, Porchia M, Refosco F, Tisato F, Sorrentino F, Scutari G, Rigobello MP, Marzano C.

Invest New Drugs. 2011 Dec;29(6):1213-23. doi: 10.1007/s10637-010-9466-7. Epub 2010 Jun 22.

PMID:
20567997
18.

High antitumor activity of 5,7-dihalo-8-quinolinolato tin(IV) complexes.

Chen ZF, Peng Y, Gu YQ, Liu YC, Liu M, Huang KB, Hu K, Liang H.

Eur J Med Chem. 2013 Apr;62:51-8. doi: 10.1016/j.ejmech.2012.12.030. Epub 2012 Dec 23.

PMID:
23353732
19.

Carbonyl-substituted titanocenes: a novel class of cytostatic compounds with high antitumor and antileukemic activity.

Gansäuer A, Winkler I, Worgull D, Lauterbach T, Franke D, Selig A, Wagner L, Prokop A.

Chemistry. 2008;14(14):4160-3. doi: 10.1002/chem.200800407. No abstract available.

PMID:
18384037
20.

Arene ruthenium complexes as anticancer agents.

Süss-Fink G.

Dalton Trans. 2010 Feb 21;39(7):1673-88. doi: 10.1039/b916860p. Epub 2009 Oct 23.

PMID:
20449402

Supplemental Content

Support Center